about
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and i...
Read More
1.87
-0.05
(-2.60%)
1.9M
XNAS Volume
XNAS 13 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Palisade Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..